Get the Stockscreener App
2.56
0.79%
0.02
After Hours:
2.61
0.05
+1.95%
Xbiotech Inc stock is traded at $2.56, with a volume of 79,519.
It is up +0.79% in the last 24 hours and down -6.91% over the past month.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
See More
Previous Close:
$2.54
Open:
$2.55
24h Volume:
79,519
Relative Volume:
1.50
Market Cap:
$78.05M
Revenue:
$4.01M
Net Income/Loss:
$-38.53M
P/E Ratio:
-2.0317
EPS:
-1.26
Net Cash Flow:
$-32.27M
1W Performance:
-3.76%
1M Performance:
-6.91%
6M Performance:
-21.95%
1Y Performance:
-65.64%
1-Day Range:
$2.55
$2.61
1-Week Range:
$2.52
$2.73
52-Week Range:
$2.50
$8.32
Xbiotech Inc Stock (XBIT) Company Profile
Name
Xbiotech Inc
Sector
Industry
Phone
512-386-2900
Address
5217 WINNEBAGO LANE, AUSTIN, TX
Compare XBIT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.56 | 77.44M | 4.01M | -38.53M | -32.27M | -1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-14-19 | Initiated | Piper Jaffray | Overweight |
| Apr-21-17 | Downgrade | Noble Financial | Buy → Hold |
| Jun-28-16 | Reiterated | Noble Financial | Buy |
Xbiotech Inc Stock (XBIT) Latest News
Using data models to predict XBiotech Inc. stock movementTrade Entry Report & Long-Term Investment Growth Plans - newser.com
What risks investors should watch in XBiotech Inc. stockBreakout Watch & Weekly High Return Stock Forecasts - newser.com
Statistical indicators supporting XBiotech Inc.’s strength2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Can volume confirm reversal in XBiotech Inc.Trend Reversal & Daily Technical Forecast Reports - newser.com
Intraday pattern recognizer results for XBiotech Inc.Quarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com
Will earnings trigger a reversal in XBiotech Inc.Weekly Investment Report & Expert Curated Trade Ideas - newser.com
Tick level data insight on XBiotech Inc. volatilityPortfolio Update Report & Low Risk Investment Opportunities - newser.com
XBiotech (NASDAQ:XBIT) Share Price Crosses Below 50-Day Moving AverageShould You Sell? - MarketBeat
Power REIT (PW): What Technical Indicators Show - fostersleader.com
How XBiotech Inc. stock valuations compare to rivalsQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com
Price action breakdown for XBiotech Inc.Exit Point & High Accuracy Buy Signal Tips - newser.com
Weiss Ratings Reiterates "Sell (E+)" Rating for XBiotech (NASDAQ:XBIT) - MarketBeat
Can VJTF Eduservices Limited Outperform the Market in a Slowing EconomyPortfolio Diversification Tips & Affordable Market Growth - earlytimes.in
How XBiotech Inc. (4XB) stock valuation compares with sectorDay Trade & Expert Approved Trade Ideas - newser.com
Using RSI to spot recovery in XBiotech Inc.2025 Retail Activity & Real-Time Stock Entry Alerts - newser.com
Will XBiotech Inc. stock rally after Fed decisionsJuly 2025 Short Interest & Low Risk High Win Rate Picks - newser.com
Is Bluerock Homes Trust Inc a good long term investmentGrowth vs. Value Investing & Free Phenomenal Trading Returns - earlytimes.in
XBiotech Signs New Executive Agreement with CEO - TipRanks
How sentiment analysis helps forecast XBiotech Inc.Weekly Trade Analysis & Safe Entry Point Identification - newser.com
Will XBiotech Inc. benefit from macro trendsLong Setup & Technical Entry and Exit Alerts - newser.com
Goldman Sachs Group Inc. Has $153,000 Holdings in XBiotech Inc. $XBIT - Defense World
Why XBiotech Inc. (4XB) stock is a strong buy callJuly 2025 Intraday Action & Community Consensus Trade Alerts - newser.com
Xbiotech Inc Stock (XBIT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):